IC
ASMB icon

Ikarian Capital’s Assembly Biosciences ASMB Stock Holding History

Ikarian Capital’s Portfolio ASMB Stock Details ASMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-12,500
Closed -$2.23M – 174
2020
Q1 		$2.23M Hold
12,500
– – 0.17% 93
2019
Q4 		$3.07M Buy
+12,500
New +$2.3M 0.5% 51

Other funds holding ASMB

DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
Alerce Investment Management Chicago, Illinois $56.8M AUM 31.17% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ikarian Capital's ASMB Position: Q2 2022 in Review

Ikarian Capital sold out of Assembly Biosciences (ASMB) in Q2 2022, closing a stake of 18,923 shares — an estimated $468K sold.

Ikarian Capital first reported a position in ASMB in Q4 2019 and held it in 10 quarters. The position peaked at $3.67M in Q2 2020. 54 funds tracked by Wall St. Rank hold ASMB as of Q2 2022.

  • Ikarian Capital reported no remaining Assembly Biosciences position as of Q2 2022 after selling out during the quarter.
  • Ikarian Capital sold 18,923 Assembly Biosciences shares in Q2 2022, an estimated $468K.
  • Ikarian Capital first reported a position in Assembly Biosciences in Q4 2019 and held it in 10 quarters.
  • Ikarian Capital's Assembly Biosciences position peaked at $3.67M in Q2 2020.
  • 54 funds tracked by Wall St. Rank held Assembly Biosciences as of Q2 2022.

Based on Ikarian Capital's 13F filing for Q2 2022, filed 12 Aug 2022.